GSA CAPITAL PARTNERS LLP – Edwards Lifesciences Corporation Transaction History
GSA CAPITAL PARTNERS LLP portfolio value:
$940,000
portfolio value
GSA CAPITAL PARTNERS LLP quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -1.00% | -115 shares | -153K | $82.63 | 11.37K |
Q2 2022 | share | Increase | 0.00% | 11.49K shares | 1.09M | $95.09 | 11.49K |
Q4 2021 | share | Decrease | -100.00% | -5.36K shares | -607K | $130.68 | 0 |
Q3 2021 | share | Decrease | -22.21% | -1.53K shares | -107K | $113.21 | 5.36K |
Q2 2021 | share | Increase | 0.00% | 6.89K shares | 714K | $103.57 | 6.89K |
Q1 2020 | share | Decrease | -13.48% | -1.31K shares | -228K | $62.87 | 8.45K |
Q4 2019 | share | Increase | 0.00% | 9.77K shares | 760K | $77.76 | 9.77K |
Q3 2019 | share | Decrease | -100.00% | -9.15K shares | -564K | $73.3 | 0 |
Q2 2019 | share | Increase | 0.00% | 9.15K shares | 564K | $61.58 | 9.15K |
Q1 2018 | share | Decrease | -100.00% | -44.67K shares | -1.67M | $46.51 | 0 |
Q4 2017 | share | Decrease | -34.01% | -23.02K shares | -789K | $37.57 | 44.67K |
Q3 2017 | share | Increase | +594.95% | 57.95K shares | 2.08M | $36.44 | 67.69K |
Q2 2017 | share | Decrease | -83.57% | -49.54K shares | -1.47M | $39.41 | 9.74K |
Q1 2017 | share | Increase | +489.21% | 49.22K shares | 1.54M | $31.36 | 59.28K |
Q4 2016 | share | Increase | +43.46% | 3.04K shares | 32K | $31.23 | 10.06K |
Q3 2016 | share | Decrease | -97.09% | -233.64K shares | -7.71M | $40.19 | 7.01K |
Q2 2016 | share | Increase | +780.66% | 213.33K shares | 7.19M | $33.24 | 240.65K |
Q1 2016 | share | Decrease | -52.10% | -29.72K shares | -698K | $29.4 | 27.32K |